Cargando…

MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is an intractable public health threat worldwide, representing the second leading cause of cancer-related mortality, with limited early detection and therapeutic options. Recent findings have revealed that the susceptibility of HCC is closely related to mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qimeng, Xu, Xueying, Wu, Mingcheng, Qin, Tiantian, Wu, Shaoning, Liu, Hongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851082/
https://www.ncbi.nlm.nih.gov/pubmed/33542895
http://dx.doi.org/10.3389/fonc.2020.562019
_version_ 1783645570848522240
author Zhang, Qimeng
Xu, Xueying
Wu, Mingcheng
Qin, Tiantian
Wu, Shaoning
Liu, Hongbo
author_facet Zhang, Qimeng
Xu, Xueying
Wu, Mingcheng
Qin, Tiantian
Wu, Shaoning
Liu, Hongbo
author_sort Zhang, Qimeng
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is an intractable public health threat worldwide, representing the second leading cause of cancer-related mortality, with limited early detection and therapeutic options. Recent findings have revealed that the susceptibility of HCC is closely related to microRNA (miRNA). We performed this systematic review with a network meta-analysis to investigated four single nucleotide polymorphisms (SNPs) that most regularly reported in miRNAs, exploring their involvement in HCC susceptibility and interaction with hepatitis B virus (HBV). METHODS: Databases were reviewed for related studies published up to May 2019 to identify all studies that compared genotypes of miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913, and miR-499 rs3746444 with no language and date restrictions. A pairwise meta-analysis was performed to estimate pooled odds ratios and 95% confidence intervals incorporating heterogeneity to assess the relationship between four miRNA polymorphisms and HCC. To further clarify the effect of polymorphisms on HCC, a Bayesian network meta-analysis was conducted to combine the effective sizes of direct and indirect comparisons. Calculations were performed by R version 3.6.1 and STATA 14.0. All steps were performed according to PRISMA guidelines. RESULTS: A total of 20 studies were enrolled in this network meta-analysis, providing 5,337 hepatocellular carcinoma cases and 6,585 controls. All included studies had an acceptable quality. Pairwise meta-analysis demonstrated that miR-196a2 rs11614913 was significantly associated with the susceptibility of HCC, while the other three SNPs were not found to have a significant association. In the analysis of HCC patients under different HBV infection status, only miR-196a2 revealed correlation of threefold risk. The network results showed no significant difference in the distribution of genotype frequencies except for miR-196a2, which appeared to have the highest superiority index when comparing and ranking four SNPs. CONCLUSION: MiR-196a2 rs11614913 was significantly associated with the susceptibility of HCC, especially for HBV- related HCC, and that individuals with TC/CC were more susceptible. No significant association was found in the other three miRNA genes. MiR-196a2 could serve as the best predictor of susceptibility in HCC.
format Online
Article
Text
id pubmed-7851082
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78510822021-02-03 MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis Zhang, Qimeng Xu, Xueying Wu, Mingcheng Qin, Tiantian Wu, Shaoning Liu, Hongbo Front Oncol Oncology BACKGROUND: Hepatocellular carcinoma (HCC) is an intractable public health threat worldwide, representing the second leading cause of cancer-related mortality, with limited early detection and therapeutic options. Recent findings have revealed that the susceptibility of HCC is closely related to microRNA (miRNA). We performed this systematic review with a network meta-analysis to investigated four single nucleotide polymorphisms (SNPs) that most regularly reported in miRNAs, exploring their involvement in HCC susceptibility and interaction with hepatitis B virus (HBV). METHODS: Databases were reviewed for related studies published up to May 2019 to identify all studies that compared genotypes of miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913, and miR-499 rs3746444 with no language and date restrictions. A pairwise meta-analysis was performed to estimate pooled odds ratios and 95% confidence intervals incorporating heterogeneity to assess the relationship between four miRNA polymorphisms and HCC. To further clarify the effect of polymorphisms on HCC, a Bayesian network meta-analysis was conducted to combine the effective sizes of direct and indirect comparisons. Calculations were performed by R version 3.6.1 and STATA 14.0. All steps were performed according to PRISMA guidelines. RESULTS: A total of 20 studies were enrolled in this network meta-analysis, providing 5,337 hepatocellular carcinoma cases and 6,585 controls. All included studies had an acceptable quality. Pairwise meta-analysis demonstrated that miR-196a2 rs11614913 was significantly associated with the susceptibility of HCC, while the other three SNPs were not found to have a significant association. In the analysis of HCC patients under different HBV infection status, only miR-196a2 revealed correlation of threefold risk. The network results showed no significant difference in the distribution of genotype frequencies except for miR-196a2, which appeared to have the highest superiority index when comparing and ranking four SNPs. CONCLUSION: MiR-196a2 rs11614913 was significantly associated with the susceptibility of HCC, especially for HBV- related HCC, and that individuals with TC/CC were more susceptible. No significant association was found in the other three miRNA genes. MiR-196a2 could serve as the best predictor of susceptibility in HCC. Frontiers Media S.A. 2021-01-19 /pmc/articles/PMC7851082/ /pubmed/33542895 http://dx.doi.org/10.3389/fonc.2020.562019 Text en Copyright © 2021 Zhang, Xu, Wu, Qin, Wu and Liu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Qimeng
Xu, Xueying
Wu, Mingcheng
Qin, Tiantian
Wu, Shaoning
Liu, Hongbo
MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis
title MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis
title_full MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis
title_fullStr MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis
title_full_unstemmed MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis
title_short MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis
title_sort mirna polymorphisms and hepatocellular carcinoma susceptibility: a systematic review and network meta-analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851082/
https://www.ncbi.nlm.nih.gov/pubmed/33542895
http://dx.doi.org/10.3389/fonc.2020.562019
work_keys_str_mv AT zhangqimeng mirnapolymorphismsandhepatocellularcarcinomasusceptibilityasystematicreviewandnetworkmetaanalysis
AT xuxueying mirnapolymorphismsandhepatocellularcarcinomasusceptibilityasystematicreviewandnetworkmetaanalysis
AT wumingcheng mirnapolymorphismsandhepatocellularcarcinomasusceptibilityasystematicreviewandnetworkmetaanalysis
AT qintiantian mirnapolymorphismsandhepatocellularcarcinomasusceptibilityasystematicreviewandnetworkmetaanalysis
AT wushaoning mirnapolymorphismsandhepatocellularcarcinomasusceptibilityasystematicreviewandnetworkmetaanalysis
AT liuhongbo mirnapolymorphismsandhepatocellularcarcinomasusceptibilityasystematicreviewandnetworkmetaanalysis